Coal beneficiation technology to reduce hazardous heavy metals in fly ash.

Fly ash emitted from the coal-fired power plant is the major contributor of the outdoor airborne particulate matters (PMs). Coal beneficiation, an industrial process to improve the quality of raw coal by removing ash-bearing components, can be a cost-effective sustainable and clean technology to reduce the emission of hazardous trace metals. As the removal efficiency of mineral matters and heavy metals within the coal is depend highly on the raw coal and the employed beneficiation process, a wide range of case studies at laboratory- and industrial-scale, published in the last 20 years, are reviewed in this study.

Quantitative frother analysis on coal mine process water with a benchtop NMR spectrometer.

This paper investigates the use of a benchtop NMR for quantification of a commonly used frothing agent, methyl isobutyl carbinol (MIBC) in the process water of a coal preparation facility. Solid phase extraction is used to increase the concentration of MIBC in the sample so that it is quantifiable by a benchtop NMR. A polymeric, reversed phase column with methanol as solvent gives a MIBC recovery rate of 67 ± 4% as determined using 400 MHz high-field NMR.

Dynamic Stabilization of Foam Films with Acoustic Sound.

This paper demonstrates the stabilization of single foam films at dynamic conditions induced by exposure to the acoustic sound. The foam films were formed from aqueous solutions using a Sheludko cell. In the presence of sound at certain sound frequencies and above certain thresholds of sound amplitude, the lifetime of the film with 1 × 10 M sodium dodecyl sulfate (SDS) in the presence of 0.

Optimal design of a simulated-moving-bed chromatographic process for high-purity separation of acetoin from 2,3-butanediol in a continuous mode.

For the high-purity production of acetoin or 2,3-butanediol (BD) from related fermentation processes, it is essential to accomplish a detailed separation between acetoin and BD in an economical mode. To address this issue, we aimed to develop a highly-efficient simulated-moving-bed (SMB) process for the continuous-mode separation of acetoin from BD with high purity and small loss. As a first step for this task, the adsorption and mass-transfer parameters of acetoin and BD on a proven adsorbent were estimated while assuming that BD isomers (meso-BD and DL-BD) would be identical in adsorption and mass-transfer behaviors.

Highly efficient recovery of xylobiose from xylooligosaccharides using a simulated moving bed method.

Xylobiose (X2), which is currently available from xylooligosaccharides (XOS), has been reported to have outstanding prebiotic function and to be highly suitable for application in food industries. This has sparked an interest in the economical production of X2 of high purity (> 99%) in food and prebiotic industries. To address such issue, we developed a highly-efficient chromatographic method for the recovery of X2 from XOS with high purity and high recovery.

Retargeting Human-Object Interaction to Virtual Avatars.

In augmented reality (AR) applications, a virtual avatar serves as a useful medium to represent a human in a different place. This paper deals with the problem of retargeting a human motion to an avatar. In particular, we present a novel method that retargets a human motion with respect to an object to that of an avatar with respect to a different object of a similar shape.

A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts.

Expression of fibroblast growth factor 2 (FGF2) is believed to be a contributing factor to the growth of a number of tumor types, including hepatocellular carcinoma (HCC). However, the potential of monoclonal antibodies that neutralize FGF2 for treatment of patients with cancer has not yet been explored in clinical trials. We therefore generated a novel monoclonal antibody (mAb), GAL-F2, specific for FGF2 and characterized its properties in vitro and in vivo.

Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts.

Purpose: Overexpression of fibroblast growth factor receptor 2 (FGFR2) may be a causative factor of a number of human tumors, especially gastric tumors of the poorly differentiated type. We investigated whether monoclonal antibodies (mAbs) directed against FGFR2 can inhibit the growth of tumors in xenograft models.

Experimental Design: We generated and characterized 3 mAbs that recognize different epitopes on FGFR2: GAL-FR21, GAL-FR22, and GAL-FR23.

Coexpression in yeast of Taxus cytochrome P450 reductase with cytochrome P450 oxygenases involved in Taxol biosynthesis.

To maximize redox coupling efficiency with recombinant cytochrome P450 hydroxylases from yew (Taxus) species installed in yeast for the production of the anticancer drug Taxol, a cDNA encoding NADPH:cytochrome P450 reductase from T. cuspidata was isolated. This single-copy gene (2,154 bp encoding a protein of 717 amino acids) resembles more closely other reductases from gymnosperms (approximately 90% similarity) than those from angiosperms (<80% similarity).

Cytoplasmic peptide:N-glycanase (PNGase) in eukaryotic cells: occurrence, primary structure, and potential functions.

A cytoplasmic peptide:N-glycanase has been implicated in the proteasomal degradation of newly synthesized misfolded glycoproteins exported from the endoplasmic reticulum. The gene encoding this enzyme (Png1p) has been identified in yeast. Based on sequence analysis, Png1p was classified as a member of the 'transglutaminase-like superfamily' that contains a putative catalytic triad of amino acids (cysteine, histidine, and aspartic acid).